BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 32092405)

  • 1. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy.
    Cai X; Wang J; Wang J; Zhou Q; Yang B; He Q; Weng Q
    Pharmacol Res; 2020 May; 155():104720. PubMed ID: 32092405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis.
    Yang F; Li H; Li Y; Hao Y; Wang C; Jia P; Chen X; Ma S; Xiao Z
    Int Immunopharmacol; 2021 Oct; 99():108051. PubMed ID: 34426110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis.
    Aydın MM; Akçalı KC
    Turk J Gastroenterol; 2018 Jan; 29(1):14-21. PubMed ID: 29391303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cellular mechanisms of liver fibrosis and its regression.
    Kisseleva T; Brenner D
    Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):151-166. PubMed ID: 33128017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells.
    Ceni E; Mello T; Polvani S; Vasseur-Cognet M; Tarocchi M; Tempesti S; Cavalieri D; Beltrame L; Marroncini G; Pinzani M; Milani S; Galli A
    J Hepatol; 2017 Apr; 66(4):754-764. PubMed ID: 27866920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.
    Devhare PB; Sasaki R; Shrivastava S; Di Bisceglie AM; Ray R; Ray RB
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice.
    Li M; Hong W; Hao C; Li L; Wu D; Shen A; Lu J; Zheng Y; Li P; Xu Y
    FASEB J; 2018 Jan; 32(1):500-511. PubMed ID: 28970250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis.
    Zhao Q; Qin CY; Zhao ZH; Fan YC; Wang K
    Tohoku J Exp Med; 2013 Jan; 229(1):35-43. PubMed ID: 23238615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques.
    Tacke F; Weiskirchen R
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):67-80. PubMed ID: 22149583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.
    Mederacke I; Hsu CC; Troeger JS; Huebener P; Mu X; Dapito DH; Pradere JP; Schwabe RF
    Nat Commun; 2013; 4():2823. PubMed ID: 24264436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHFR silence alleviated the development of liver fibrosis by affecting the crosstalk between hepatic stellate cells and macrophages.
    Peng Y; Li Z; Chen S; Zhou J
    J Cell Mol Med; 2021 Nov; 25(21):10049-10060. PubMed ID: 34626074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review).
    Zhang Y; Wu Y; Shen W; Wang B; Yuan X
    Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35506449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
    Foglia B; Cannito S; Bocca C; Parola M; Novo E
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Stellate Cell: A Double-Edged Sword in the Liver.
    Luo N; Li J; Wei Y; Lu J; Dong R
    Physiol Res; 2021 Dec; 70(6):821-829. PubMed ID: 34717063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
    Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A
    J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells.
    Kim J; Jung Y
    Vitam Horm; 2016; 102():121-49. PubMed ID: 27450733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis.
    Ezhilarasan D
    J Cell Physiol; 2022 Jan; 237(1):436-449. PubMed ID: 34514599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?
    Yi HS; Jeong WI
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():99-104. PubMed ID: 23855303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.